|
|
(2014). Potential breakthrough in Alzheimer's diagnosis. A retinal imaging device may detect symptoms 15-20 years before clinical diagnosis. Duke Med Health News, 20(9), 1–2.
Keywords: Alzheimer Disease/*diagnosis; *Diagnostic Imaging; *Early Diagnosis; Humans; Retina/*pathology
|
|
|
|
(2014). Potential breakthrough in Alzheimer's diagnosis. A retinal imaging device may detect symptoms 15-20 years before clinical diagnosis. Duke Med Health News, 20(9), 1–2.
Keywords: Alzheimer Disease/*diagnosis; *Diagnostic Imaging; *Early Diagnosis; Humans; Retina/*pathology
|
|
|
|
(2014). Retraction: “Technological turbulence and the impact of exploration and exploitation within and across organizations on product development performance” by Ulrich Lichtenthaler. Entrepreneurship Theory and Practice, 38(4), 979.
Abstract: The above article from Entrepreneurship Theory and Practice, “Technological turbulence and the impact of exploration and exploitation within and across organizations on product development performance,” by Ulrich Lichtenthaler, published online on April 2012 in Wiley Online Library, DOI: 10.1111/j.1540-6520.2012.00520.x, has been retracted by agreement between the author, the Executive Editor, D. Ray Bagby, and Wiley Periodicals, Inc. The retraction has been agreed before print publication based on discussions about the presentation of the empirical results.
|
|
|
|
(2014). Retraction: “The Impact of Family Involvement on Dynamic Innovation Capabilities: Evidence From German Manufacturing Firms” by Ulrich Lichtenthaler and Miriam Muethel. Entrepreneurship Theory and Practice, 38(4), 977.
Abstract: The above article from Entrepreneurship Theory and Practice, “The Impact of Family Involvement on Dynamic Innovation Capabilities: Evidence From German Manufacturing Firms,” ' by Ulrich Lichtenthaler and Miriam Muethel, published online in 2012 in Wiley Online Library, DOI: 10.1111/j.1540-6520.2012.00548.x, and in the November 2012 print issue (Vol. 36-6) has been retracted by agreement between the primary author, Ulrich Lichtenthaler, the Executive Editor, D. Ray Bagby, and Wiley Periodicals, Inc. The retraction has been agreed based on discussions about the presentation of the empirical results. The second author was not involved in the empirical analyses and was unaware of the reasons for these discussions. The first author assumes full responsibility.
|
|
|
|
(2014). Two new GLP-1 receptor agonists for diabetes. Med Lett Drugs Ther, 56(1455), 109–111.
Keywords: Diabetes Mellitus, Type 2; Drug Approval; Drug Interactions; Drug Therapy, Combination; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Immunoglobulin Fc Fragments; Incretins; Randomized Controlled Trials as Topic; Receptors, Glucagon; Recombinant Fusion Proteins; United States; United States Food and Drug Administration
|
|
